<p class="MsoNormal">Published in association with Cancer Research UK</p> <p class="MsoNormal">One of the most-cited general cancer journals, publishing significant and innovative research under six broad headings: Clinical Studies, Translational Therapeutics, Molecular Diagnostics, Cellular and Molecular Biology, Genetics and Genomics, and Epidemiology</p> http://feeds.nature.com/bjc/rss/current Nature Publishing Group en © 2025 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. British Journal of Cancer © 2025 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. [email protected]

https://www.nature.com/uploads/product/bjc/rss.png http://feeds.nature.com/bjc/rss/current https://www.nature.com/articles/s41416-025-03138-7 British Journal of Cancer, Published online: 05 August 2025; doi:10.1038/s41416-025-03138-7Effect of risk-based screening for upper gastrointestinal cancers: a multi-center real-world study]]> Hongrui TianMengfei LiuZhen LiuChao ShiLei ChenYine ZhangMei LiXiaoli LiYincheng MaXiaoming MaYingying LiangRuichun ShiHongli LiuHongchen ZhengWenlei YangYaqi PanHuanyu ChenJinhan LvZhonghu HeYang Ke doi:10.1038/s41416-025-03138-7 British Journal of Cancer, Published online: 2025-08-05; | doi:10.1038/s41416-025-03138-7 2025-08-05 British Journal of Cancer 10.1038/s41416-025-03138-7 https://www.nature.com/articles/s41416-025-03138-7 https://www.nature.com/articles/s41416-025-03133-y British Journal of Cancer, Published online: 04 August 2025; doi:10.1038/s41416-025-03133-yMoving beyond cytotoxicity in cancer immunotherapy: embracing tumor microenvironment remodeling for durable control]]> Nicholas KoelschMasoud H. Manjili doi:10.1038/s41416-025-03133-y British Journal of Cancer, Published online: 2025-08-04; | doi:10.1038/s41416-025-03133-y 2025-08-04 British Journal of Cancer 10.1038/s41416-025-03133-y https://www.nature.com/articles/s41416-025-03133-y https://www.nature.com/articles/s41416-025-03129-8 British Journal of Cancer, Published online: 31 July 2025; doi:10.1038/s41416-025-03129-8Randomised phase-2 screening trial of intermittent energy restriction plus resistance exercise versus resistance exercise alone during chemotherapy for advanced breast cancer]]> Michelle HarvieMary PegingtonAnthony HowellYit LimKaren LivingstoneDanielle RoseDebbie McMullanAnthony MaxwellEmma BarrettKatharine SellersSuzanne KrizakSacha J. Howell doi:10.1038/s41416-025-03129-8 British Journal of Cancer, Published online: 2025-07-31; | doi:10.1038/s41416-025-03129-8 2025-07-31 British Journal of Cancer 10.1038/s41416-025-03129-8 https://www.nature.com/articles/s41416-025-03129-8 https://www.nature.com/articles/s41416-025-03132-z British Journal of Cancer, Published online: 30 July 2025; doi:10.1038/s41416-025-03132-zPredictive efficacy and role of 2HG in MGMT promoter methylation in gliomas: a retrospective study based on MRS and mediator variable analysis]]> Ying GeMeimei YuTianjing ChangZixuan WangYang ZhangHongyan ChenXuzhu ChenXin LiNan JiHuicong Shen doi:10.1038/s41416-025-03132-z British Journal of Cancer, Published online: 2025-07-30; | doi:10.1038/s41416-025-03132-z 2025-07-30 British Journal of Cancer 10.1038/s41416-025-03132-z https://www.nature.com/articles/s41416-025-03132-z https://www.nature.com/articles/s41416-025-03118-x British Journal of Cancer, Published online: 29 July 2025; doi:10.1038/s41416-025-03118-xPrognostic factors in patients with relapsed high-grade osteosarcoma: a systematic review]]> Alba Rubio-San-SimónWilliam WilsonGiovanna SironiMarie-Cécile le DeleyEmanuela PalmeriniNathalie GasparSophie Piperno-NeumannStefanie Hecker-NoltingSandra StraussRoelof van EwijkCristina MeazzaMarie-Cécile le DeleyRoelof van Ewijk doi:10.1038/s41416-025-03118-x British Journal of Cancer, Published online: 2025-07-29; | doi:10.1038/s41416-025-03118-x 2025-07-29 British Journal of Cancer 10.1038/s41416-025-03118-x https://www.nature.com/articles/s41416-025-03118-x https://www.nature.com/articles/s41416-025-03114-1 British Journal of Cancer, Published online: 28 July 2025; doi:10.1038/s41416-025-03114-1The pronounced cytotoxic effects of chimeric antigen receptor T cells targeting B7-H3 in organoids and liver xenografts derived from colorectal cancer patients]]> Yuling ShengLi YanQi LiuYifan PengJingyun TanWenhua LiWei MaoWenqing WeiYanyun ChangLinlin CaoYi TanYanlin XiaoWenyong ZhangJing GaoYang XuChangzheng Du doi:10.1038/s41416-025-03114-1 British Journal of Cancer, Published online: 2025-07-28; | doi:10.1038/s41416-025-03114-1 2025-07-28 British Journal of Cancer 10.1038/s41416-025-03114-1 https://www.nature.com/articles/s41416-025-03114-1 https://www.nature.com/articles/s41416-025-03126-x British Journal of Cancer, Published online: 28 July 2025; doi:10.1038/s41416-025-03126-xEnhanced HER2 internalization by clathrin-dependent endocytosis in non-small cell lung cancer positive for HER2 mutations]]> Atsushi ShimauchiEiji IwamaRitsu IbusukiHirono TsutsumiDaisuke ShibaharaKohei OtsuboYasuto YoneshimaKentaro TanakaIsamu Okamoto doi:10.1038/s41416-025-03126-x British Journal of Cancer, Published online: 2025-07-28; | doi:10.1038/s41416-025-03126-x 2025-07-28 British Journal of Cancer 10.1038/s41416-025-03126-x https://www.nature.com/articles/s41416-025-03126-x https://www.nature.com/articles/s41416-025-03127-w British Journal of Cancer, Published online: 26 July 2025; doi:10.1038/s41416-025-03127-wA cancer-associated TP53 synonymous mutation induces synthesis of the p53 isoform p53/47]]> Rhythm SajwanLixiao WangOlivera Casar-BorotaKonstantinos KarakostisSa ChenRobin FahraeusXiaolian GuSivakumar Vadivel Gnanasundram doi:10.1038/s41416-025-03127-w British Journal of Cancer, Published online: 2025-07-26; | doi:10.1038/s41416-025-03127-w 2025-07-26 British Journal of Cancer 10.1038/s41416-025-03127-w https://www.nature.com/articles/s41416-025-03127-w